Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

MicroDiag of Suzhou Presents Innovative Cancer Diagnostic at ASCO

publication date: Jun 4, 2014
MicroDiag Biomedicine, a Suzhou maker of cancer diagnostic tests, was invited to present its serum circulating DNA mutation detection assay at the recent ASCO meeting in Chicago. The test, which MicroDiag calls the MCA-qASA assay, allows clinicians to personalize chemotherapy when no tumor tissue sample is available. MicroDiag will complete a China clinical trial of the assay and hopes to market it in early 2015. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital